BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

CLARIS Lifesciences in Talks to Sell Injectables Business for $250 - $300 Million


11/26/2012 8:06:33 AM

Ahmedabad-based Claris Lifesciences seems to be in preliminary talks with Japanese Pharma company Otsuka Pharma for selling its injectables business. The valuation for the deal is likely to be in the range of $250 - $300 million. IDFC and Barclays are the bankers to the deal, a person close to the development told ET Now. More than half of the revenues for Claris comes in from the injectables business and is the key contributor for growth for the company. The management of Claris Lifesciences did not respond to the queries of ET Now. This news comes on the back of media reports a few weeks ago that Strides Arcolab was in discussion with Pfizer to sell its injectables business Agila.



   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->